Food and Drug Administration

Center for Drug Evaluation and Research

Endocrinologic and Metabolic Drugs Advisory Committee

January 15, 2003



The following people have enrolled to speak at the Open Public Hearing at today’s session:



Abbey S. Meyers - National Organization for Rare Disorders, Inc.

Melissa Bryant - Charlotte, NC

Stephen E. Holland - National MPS Society, Inc.

Linda L. Day - Sheridan, Montana

Mark A. Dant - Carrollton, Texas

J.E. Wraith, MB, ChB, FRCPHC - Royal Manchester Children's Hospital

Denise Dengel - Seattle, Washington

Eric Merrell - Herculaneum, Missouri






In addition, letters and e-mails were submitted from the public. Copies of these have been provided to the Committee and are available for public viewing in the two binders at the Information Desk. They will also be posted on the FDA website after the meeting and are considered part of the permanent meeting record.